Kassi Jackson Filkins, Editor

Jim Sluck, VP of Marketing for Sight Sciences' TearCare, shares the impetus behind the company's fair access campaign.

Nidhi Rana, OD, discusses key highlights from her AAOpt 2022 presentation on pediatric red eye.

Derek Cunningham, OD, FAAO, gives key takeaways from his AAOpt 2022 discussion, "Back to the basics: The importance of treating inflammation AND obstruction for dry eye."

Jeff Nau, PhD, president and CEO of Oyster Point Pharma shares an update on the company's Tyrvaya product.

Optometry Times' EyeCon co-chairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, MA, OD, FAAO, reflect on the 2023 EyeConversations keynote address, which covered new technology, artificial intelligence, and an update in pharmacology.

Graham Erickson, OD, gives key takeaways from his discussion titled, "Optimizing visual performance for sports,"

The positive 3-month efficacy and safety results from Azura Ophthalmic's Phase 2b study of AZR-MD-001 0.5% in Meibomian Gland Dysfunction (MGD) met its co-primary endpoints.

Sherrol Reynolds, OD, gives key takeaways from her co-presentation on the most common autoimmune diseases and their latest updates, which she discussed at AAOpt 2022.

Stephanie Woo, OD, FAAO, FSLS, and S. Barry Eiden, OD, FAAO, discuss the Keratoconus Essentials Program, a joint effort between Woo University and the International Keratoconus Academy.

This acquisition for Alcon means a growing ophthalmic portfolio of commercial products and development pipeline.

Jacqueline Theis, OD, FAAO, gives key takeaways from her discussion on treating photophobia in patients, which she presented during the 2022 American Academy of Optometry meeting.

Parres Wright, OD, FAAO, shares highlights from her discussion, "Diabetes and low vision rehabilitation," which she presented during AAOpt 2022.

Chris Kenrick, OD, shares what she finds to be most important from her discussion this year at AAOpt 2022.

Jessica Steen, OD, FAAO, gave an ophthalmic therapeutic update during the 2022 American Academy of Optometry Meeting.

Brad Sutton, OD, FAAO, FORS, discusses key takeaways from his discussion, "Genetic testing in AMD: critical, useful, or inappropriate," which he presented during the 2022 American Academy of Optometry meeting.

Jack Phu, OD, MPH, PhD, with UNSW Sydney, discusses key takeaways from his AAOpt 2022 presentation that looked at visual fields in 2022.

Albert Swann share details about Bausch + Lomb's new healthcare product line for dogs: Project Watson.

Aziz Mottiwala, the Chief Commercial Officer at Tarsus Pharmaceuticals, shares a pipeline update.

Optometry Times®' EyeCon 2022 co-chairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, MA, OD, FAAO, sat down with Ben Casella, OD, FAAO, chief optometric editor for Optometry Times® to chat all-things EyeCon 2022.

Graham Erickson, OD, shares highlights from his AAOpt 2022 presentation, "Optimizing visual performance for sports."

Erin Rueff, OD, PhD, FAAO, shares highlights from her 2022 American Academy of Optometry presentations in the contact lens space.

Anthony DeWilde, OD, FAAO, shares highlights from his AAOpt presentation, "What a pain! An optometrist's guide to headaches."

Alexis G. Malkin, OD, FAAO, and Anita Gulmiri, OD, FAAO, share highlights from their presentation, "Intersection of low vision and contact lens: unique examples of co-management," which they presented during AAOpt 2022.

Blair Lonsberry, MS, OD, MEd, FAAO, shares highlights from his 2022 American Academy of Optometry presentation, "Simplifying systemic antibiotics."

Sherrol A. Reynolds, OD, FAAO, shares highlights from her discussion, "The OD's role in addressing silent killers: diabetes, hypertension, and dyslipidemia," which she presented during this year's American Academy of Optometry annual meeting.

Parres Wright, OD, FAAO, shares highlights from her discussion, "DEI Building Blocks, its foundational concepts understanding diversity, equity, and inclusion in optometry," which she co-presented during AAOpt 2022.

Graham Erickson, OD, FAAO, FCOVD, shares highlights from his 2022 American Academy of Optometry presentation, "Evidence-based refractive prescribing for pediatric patients."

The CHAMP phase 3 study shows strong safety and efficacy of NVK002 for the treatment of myopia.

Jason S. Ng, OD, PhD, FAAO, shares highlights from his 2022 American Academy of Optometry presentation, "Cannabis and vision: acute effects."

Brad Sutton, OD, FAAO, FORS, discusses key takeaways from his discussion, "Topical pharmacology rounds," which he presented during the 2022 American Academy of Optometry meeting.